Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leap Therapeutics, Inc. - Common Stock (NQ:LPTX)

0.4735 -0.0565 (-10.66%)
Streaming Delayed Price Updated: 2:39 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Leap Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Unusual volume stocks are being observed in Tuesday's session.
On Tuesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Why Is Leap Therapeutics Down 9% In Pre-Market Trading?
Leap Therapeutics is trading lower in pre-market following a $58.9 million private placement led by Winklevoss Capital. 
Via Benzinga
These stocks are moving in today's session
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Biotech Goes Bitcoin: Leap Therapeutics Surges 29% on Groundbreaking Crypto Treasury Deal with Winklevoss Capital
October 6, 2025 – In a seismic shift that reverberated across both traditional financial markets and the burgeoning crypto ecosystem, Leap Therapeutics (NASDAQ: LPTX), a clinical-stage biotechnology... 
Via BreakingCrypto
Topics ETFs Economy
Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data
Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant... 
Via MarketMinute
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Which stocks are moving on Friday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Which stocks are moving before the opening bell on Thursday?
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Leap Therapeutics Slashes R&D Spending
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
These stocks are moving in today's pre-market session
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
Via Chartmill
In today's session, these stocks are experiencing unusual volume.
Unusual volume stocks are being observed in Thursday's session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
These stocks are the most active in today's session
Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer
Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans. 
Via Benzinga
Top movers in Wednesday's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
The trading volume of these stocks is deviating from the norm in today's session.
Which stocks have an unusual volume on Wednesday? 
Via Chartmill
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline
While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival... 
Via Stocktwits
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.